Tagged with “Sutent”

Phase III Sutent Trial for Colorectal Cancer Discontinued

Pfizer announced yesterday, June 30, 2009, that they are discontinuing a phase III trial comparing FOLFIRI chemotherapy alone to FOLFIRI with added Sutent® (sunitinib).

Based on results so far, the independent Data Monitoring Committee (DMC) determined that a significant reduction in progression-free survival was not statistically possible. No new safety concerns were identified. Continue reading…

Posted by Kate Murphy on July 1st, 2009
Posted in: Research & Treatment News | No Comments »
Tags: clinical trials, sunitinib, Sutent

Search C3

Win Tickets to the US Open Series

Make a donation to the Colorectal Cancer Coalition before Aug 5th for a chance to win tickets to the US Open Series in the following cities: Washington, DC; San Diego, CA; Cincinnati, OH; and New Haven, CT.

Donate and enter!

Good luck!

Sweepstakes ends on Thursday, August 5. Click here for official rules.

Follow C3

Join us on Facebook

Watch us on YouTube

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.